These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N. Am J Surg Pathol; 2008 Apr 02; 32(4):544-52. PubMed ID: 18300793 [Abstract] [Full Text] [Related]
7. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions. Masood S. Clin Lab Med; 2005 Dec 02; 25(4):713-31, vi. PubMed ID: 16308088 [Abstract] [Full Text] [Related]
8. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Moritani S, Kushima R, Sugihara H, Bamba M, Kobayashi TK, Hattori T. Mod Pathol; 2002 Apr 02; 15(4):397-405. PubMed ID: 11950913 [Abstract] [Full Text] [Related]
9. Epithelial stem cells and their possible role in the development of the normal and diseased human breast. Rudland PS. Histol Histopathol; 1993 Apr 02; 8(2):385-404. PubMed ID: 8490267 [Abstract] [Full Text] [Related]
10. [Ki 67 growth fraction in carcinomas and benign lesions of the breast]. Kunz J, Schmidt A. Zentralbl Pathol; 1993 Aug 02; 139(3):201-5. PubMed ID: 8218121 [Abstract] [Full Text] [Related]
11. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries. Gould VE, Mosquera JM, Leykauf K, Gattuso P, Dürst M, Alonso A. Hum Pathol; 2005 May 02; 36(5):536-45. PubMed ID: 15948121 [Abstract] [Full Text] [Related]
12. Immunohistochemical study in breast carcinoma. S100-protein positive cells and neuroendocrine differentiation. Zółtowska A, Moszkowska G, Zamorska B, Roszkiewicz A. Arch Immunol Ther Exp (Warsz); 1996 May 02; 44(4):271-7. PubMed ID: 9017169 [Abstract] [Full Text] [Related]
13. [Current theories on the nature of myoepithelial cells and their role in the morphogenesis of dyshormonal hyperplasia and breast neoplasms]. Karelina TV. Arkh Patol; 1982 May 02; 44(2):69-73. PubMed ID: 6280649 [Abstract] [Full Text] [Related]
14. Mucinous breast lesions: diagnostic challenges. Tan PH, Tse GM, Bay BH. J Clin Pathol; 2008 Jan 02; 61(1):11-9. PubMed ID: 17873114 [Abstract] [Full Text] [Related]
15. Nuclear morphometry of benign and malignant breast lesions. Skjørten F, Kaaresen R, Jacobsen U, Skaane P, Amlie E. Eur J Surg Oncol; 1991 Aug 02; 17(4):350-3. PubMed ID: 1874292 [Abstract] [Full Text] [Related]
16. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast. Hilson JB, Schnitt SJ, Collins LC. Am J Surg Pathol; 2010 Jun 02; 34(6):896-900. PubMed ID: 20463570 [Abstract] [Full Text] [Related]
17. Cathepsin-D expression in breast lesion: an immunohistochemical study. Brujan I, Mărgăritescu C, Simionescu C, Pirici D, Fronie A, Foarfă C, Stepan A, Vrabete M. Rom J Morphol Embryol; 2009 Jun 02; 50(1):31-9. PubMed ID: 19221643 [Abstract] [Full Text] [Related]
18. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. Viacava P, Naccarato AG, Bocci G, Fanelli G, Aretini P, Lonobile A, Evangelista G, Montruccoli G, Bevilacqua G. J Pathol; 2004 Oct 02; 204(2):140-6. PubMed ID: 15376259 [Abstract] [Full Text] [Related]
19. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Rabban JT, Koerner FC, Lerwill MF. Hum Pathol; 2006 Jul 02; 37(7):787-93. PubMed ID: 16784976 [Abstract] [Full Text] [Related]
20. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast. Bofin AM, Lydersen S, Hagmar BM. Diagn Cytopathol; 2004 Oct 02; 31(4):207-15. PubMed ID: 15452908 [Abstract] [Full Text] [Related] Page: [Next] [New Search]